Abstract
Human leukocyte interferon (HuLeIF) preparations contain distinct molecular forms of interferon exhibiting significant heterogeneties in sizes when analyzed by electrophoresis in sodium dodecyl sulfate (NaDodSO(4))/polyacrylamide gels, migrating in two broad bands of activity with peaks at about 21,000 and 15,000 daltons. HuLeIFs exhibit extensive charge heterogeneities when analyzed by isoelectric focusing, resolving into several major peaks of approximately equal activity distributed from pH 5.7 to 7.0. When HuLeIF preparations are treated with 0.01 M sodium periodate buffer, pH 4.5, at 4 degrees , both the size and charge heterogeneities rapidly disappear: periodate-treated HuLeIF migrates as a single, narrow band at 15,000 daltons in NaDodSO(4)/polyacrylamide gels and focuses as a single, narrow band at pH 5.7. Quantitative considerations suggest that either the larger, heterogeneously charged HuLeIFs are converted to the smaller, size- and charge-homogeneous interferon by extensive chemical deglycosylation, or, alternatively, the smaller, 15,000 dalton, pH 5.7 interferon is much more stable to periodate treatment than are the other interferon forms. However, the activity of each of the variously charged forms of HuLeIF isolated from focusing gels exhibited the same stability as the pH 5.7 component; similarly, the activity of each of the size-forms of HuLeIF isolated from NaDodSO(4)/polyacrylamide gels exhibited the same stability as the 15,000-dalton interferon.
MeSH Terms
Chemical Phenomena
Chemistry
Electrophoresis, Polyacrylamide Gel
Humans
Interferons/physiology
Isoelectric Focusing
Leukocytes/analysis
Oxidation-Reduction
Parainfluenza Virus 1, Human
Periodic Acid
Chemicals
Periodic Acid
Interferons
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Stewart W E
Lin L S
Wiranowska-Stewart M
Cantell K
References (24)
24 references, click to expand
-
Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.
J Exp Med. 1976 Nov 2;144(5):1316-23
PMID: 186555
-
Biological properties of human leukocyte interferon components.
J Gen Virol. 1977 May;35(2):341-51
PMID: 69014
-
De novo cell-free synthesis of human interferon.
Ann N Y Acad Sci. 1977 Mar 4;284:697-702
PMID: 280158
-
Relationship between the physicochemical nature of human interferon, the cell induced, and the inducing agent.
Antimicrob Agents Chemother. 1977 Feb;11(2):291-8
PMID: 557953
-
Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation.
J Biol Chem. 1977 Jun 25;252(12):4425-7
PMID: 863934
-
Purification of interferon by adsorption chromatography on controlled pore glass.
J Gen Virol. 1976 Dec;33(3):517-21
PMID: 1036458
-
Pronounced antiviral activity of human interferon on bovine and porcine cells.
Nature. 1974 Oct 11;251(5475):543-5
PMID: 4371444
-
Distinct molecular species of interferons.
Virology. 1974 Sep;61(1):80-6
PMID: 4369929
-
No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):305-10
PMID: 4368958
-
Two antigenically distinct species of human interferon.
Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185-7
PMID: 49055
-
Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity.
J Biol Chem. 1976 Mar 25;251(6):1659-62
PMID: 176158
-
Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells.
Virology. 1976 Apr;70(2):451-8
PMID: 178096
-
High resolution two-dimensional electrophoresis of proteins.
J Biol Chem. 1975 May 25;250(10):4007-21
PMID: 236308
-
Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.
J Gen Virol. 1975 Mar;26(3):327-31
PMID: 164521
-
Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity.
Virology. 1975 Sep;67(1):68-73
PMID: 170740
-
Stabilisation of mouse and human interferons by acid pH against inactivation due to shaking and guanidine hydrochloride.
Proc Soc Exp Biol Med. 1974 May;146(1):249-53
PMID: 4827258
-
Recent developments in chemical modification and sequential degradation of proteins.
Adv Protein Chem. 1970;24:261-308
PMID: 4915249
-
Identification of the cell multiplication inhibitory factors in interferon preparations as interferons.
Nature. 1976 Jul 22;262(5566):300-2
PMID: 958376
-
Nature of the molecular heterogeneity of human leukocyte interferon.
J Virol. 1976 Aug;19(2):425-34
PMID: 957478
-
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.
N Engl J Med. 1976 Sep 2;295(10):517-22
PMID: 950957
-
Interferon: purification and initial characterization from human diploid cells.
Proc Natl Acad Sci U S A. 1976 Feb;73(2):520-523
PMID: 1061154
-
Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction.
Biochemistry. 1976 Feb 10;15(3):704-13
PMID: 1252420
-
Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
J Virol. 1975 Nov;16(5):1124-30
PMID: 1185850
-
Molecular weight study of human fibroblast interferon.
Biochem Biophys Res Commun. 1975 Jul 8;65(1):107-12
PMID: 1147973